Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday 14Th February 2026 And Submission Of Un-Audited Financial Results (Standalone) For The Third Quarter And Nine Months Ended On 31St December 2025.
14-Feb-2026 | Source : BSEPursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that the Board of Directors of Gujarat Inject Kerala Limited (the company) at its meeting held today i.e. Saturday 14th February 2026 has inter alia discussed approved and taken on record the following agenda: 1. approved Un-Audited Financial Results (Standalone) of the Company for the Third Quarter and Nine Months ended on 31st December 2025; and 2. took on record Limited Review Report thereon issued by M/s. S. Mandawat & Co. Statutory Auditors of the Company.
Results - Financial Results For The Quarter Ended On 31/12/2025
14-Feb-2026 | Source : BSEAs attached
Board Meeting Intimation for Gujarat Inject (Kerala) Limited Scheduled To Be Held On Saturday 14Th February 2026 For Consideration & Approval Of Un-Audited Financial Results For The Third Quarter And Nine Months Ended On 31St December 2025
11-Feb-2026 | Source : BSEGujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Un-Audited Financial Results for the Third Quarter and Nine Months ended on 31st December 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






